Market Reports

Cancer Personalized Medicine 2008

The Cancer Personalized Medicine marketplace represents the paradigm for personalized medicine market evolution and Select Biosciences focuses in this report on the various commercialized cancer predictor tests, their current status, traction in the marketplace, quantitative market opportunities, and the factors that are driving as well as challenging the expansion of this space. Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses i

Multiplexed Diagnostics 2009 Market Report

Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized.

Multiplexed Diagnostics 2010

The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points.

Single Cell Analysis 2010: the New Frontier for 'Omics Market Report

Successful conversion of opportunity to profit requires a detailed understanding of this emerging market. Single-Cell Analysis 2010: the New Frontier for ’Omics explains the key technologies, applications, unmet needs and trends. The 128-page report includes a survey of more than 300 participants, interviews with 5 leading experts, analyses of 25 companies and 16 academic programs and a 5-by-7 quantitative market model of technologies and applications.

Tissue Engineering & Stem Cell Technology Report 2007

The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a complex regulatory structure still to overcome, yet continued high level investment, many of your competitors are aware of the the commercial opportunities within Tissue Engineering & Stem Cell Technology.